Muhammad B. Khan
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Distinct transport cycle and lipid regulation of a Mg2+-transporting P-type ATPase, MgtA.
Journal: Research square
Published: May 18, 2026
The Effect of Deuteration and Homologation of the Lactam Ring of Nirmatrelvir on Its Biochemical Properties and Oxidative Metabolism.
Journal: ACS bio & med chem Au
Published: June 28, 2023
SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals.
Journal: ACS central science
Published: January 11, 2023
Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition.
Journal: Frontiers in chemistry
Published: January 11, 2022
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors.
Journal: RSC medicinal chemistry
Published: July 22, 2021
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability.
Journal: Journal of medicinal chemistry
Published: July 09, 2021
Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies.
Journal: European journal of medicinal chemistry
Published: March 15, 2021
N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer.
Journal: Journal of molecular biology
Published: March 01, 2021
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Journal: Nature communications
Published: October 21, 2020
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Journal: Nature communications
Published: April 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026